Response to interferon treatment in essential thrombocythemia with inv(3)(q21q26)
RG has taken care of the patient and written the manuscript; AJC was consulted about the chromosomal abnormalities, reviewed material, and edited manuscript; and JTP treated the patient, organized studies, and has written the manuscript.
NIH-P01CA108671 (Sub PI: Prchal), Hematology Training grant T32DK007115 (CoPI: Prchal, Fellow: R Gangaraju)
Compliance with ethical standards
Ethics committee or IRB approval is not required for the publication of this single case report. Details that might disclose the identity of the patient are not included in this manuscript.
- 4.Reiter E, Greinix H, Rabitsch W, Keil F, Schwarzinger I, Jaeger U, Lechner K, Worel N, Streubel B, Fonatsch C, Mitterbauer G, Kalhs P (2000) Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversion inv (3)(q21q26) or homologous translocation t(3;3) (q21;q26). Ann Hematol 79:374–377CrossRefGoogle Scholar